Alkermes Plc (ALKS)
31.91
-0.09
(-0.28%)
USD |
NASDAQ |
Feb 20, 16:00
31.86
-0.05
(-0.16%)
After-Hours: 20:00
Alkermes EPS Diluted (Quarterly) : 0.4911 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 0.0002 |
| Krystal Biotech, Inc. | 1.699 |
| Assertio Holdings, Inc. | 1.612 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Jazz Pharmaceuticals Plc | 4.081 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 82.76M |
| Revenue (Quarterly) | 394.18M |
| Total Expenses (Quarterly) | 311.42M |
| Enterprise Value | 4.229B |
| Gross Profit Margin (Quarterly) | 86.56% |
| Profit Margin (Quarterly) | 21.00% |
| Earnings Yield | 6.33% |
| Operating Earnings Yield | 6.69% |
| Normalized Earnings Yield | 6.345 |